Moreover, the mTOR signaling pathway is regulated by IGFBP2 in cancer; we next examined the effect on AKT/mTOR signaling pathway with IGFBP2 blockade in mouse models of lupus. Here, IGFBP2 is linked to systemic lupus erythematosus.